The wound care management market comprises of dressings, equipment and other aids to prevent and treat wounds and quicken or promote wound healing. Wound debridement devices are special devices used to remove dead or unhealthy tissue from a wound to promote healing. GlobalData uses proprietary data and analytics to provide a comprehensive report on the wound debridement devices devices market, including market shares of different players within Australia. Buy the latest report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Australia Wound Debridement Devices Market Share

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

In 2022, GlobalData’s Market Model methodology determined that the leading player in the wound debridement devices market in Australia was Smith & Nephew followed by Soring, Zimmer Biomet, Becton Dickinson and Co and Lohmann & Rauscher.

Debridement can be done by various methods, for example autolytic wound debridement devices (which include wet to dry dressings), enzymatic debridement (which are ointments contain enzymatic agents), mechanical debridement, hydrosurgery debridement devices, low frequency ultrasound devices, surgical debridement devices, and maggot therapy. Autolytic wound debridement devices, surgical debridement devices, enzymatic debridement agents and maggot therapy are not tracked under this category.

Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the wound debridement devices devices market within Australia was expected to be over $1m in 2022.

For the latest complete market share analysis of wound debridement devices device market in Australia, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.